Abiopharma

(100% Positive) COLLEGIUM PHARMACEUTICAL, INC. (COLL) Announces Business Combination

(80% Positive) Century Therapeutics, Inc. (IPSC) Provides Update on program for Type 1 Diabetes PHILADELPHIA

(90% Positive) XENCOR, INC. (XNCR) Announces Enrollment Update for data Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(85% Positive) BONE BIOLOGICS CORPORATION (BBLGW) Announces Enrollment Update for products Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

Guardant Health, Inc. - Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

(99% Neutral) Spruce Biosciences, Inc. (SPRB) Announces Regulatory Update

InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation

(80% Positive) Personalis, Inc. (PSNL) Provides Update on results for breast cancer surveillance

EPAM Systems, Inc. - EPAM and Cursor Announce Strategic Partnership to Build and Scale AI-Native Teams for Global Enterprises

MannKind Provides Business Updates and 2026 Growth Drivers

CorMedix Therapeutics Announces Leadership and Board Updates

Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

BioVie Inc. - BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of Americas Most Successful Small-Cap Companies

CoyaTherapeutics - Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients